Texas Yale Capital Corp. Bristol Myers Squibb CO Transaction History

Texas Yale Capital Corp.

$2.47 Billion
Q4 2024

A detailed history of Texas Yale Capital Corp. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Texas Yale Capital Corp. holds 9,050 shares of BMY stock, worth $543,724. This represents 0.02% of its overall portfolio holdings.

Number of Shares

9,050

Previous 9,050 -0.0%

Holding current value

$543,724

Previous $468,000 9.19%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $35,420 - $46,631	-880 Reduced 8.86%	9,050 $375,000
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $187,132 - $223,301	-3,860 Reduced 27.99%	9,930 $509,000
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $7,525 - $8,414	-130 Reduced 0.93%	13,790 $800,000
Q2 2023 Aug 03, 2023	SELL	$63.71 - $70.74 $46,826 - $51,993	-735 Reduced 5.02%	13,920 $890,000
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $47 - $28,123	-366 Reduced 2.44%	14,655 $1.04 Million
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $47,032 - $56,395	765 Added 5.37%	15,021 $1.1 Million
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $1,877 - $2,188	35 Added 0.25%	14,256 $889,000
Q3 2021 Nov 08, 2021	BUY	$59.17 - $69.31 $3,550 - $4,158	60 Added 0.42%	14,221 $841,000
Q2 2021 Aug 05, 2021	BUY	$61.91 - $67.42 $11,453 - $12,472	185 Added 1.32%	14,161 $946,000
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $22,845 - $25,694	385 Added 2.83%	13,976 $882,000
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $12,125 - $13,740	-210 Reduced 1.52%	13,591 $843,000
Q2 2020 Jul 31, 2020	BUY	$54.82 - $64.09 $166,652 - $194,833	3,040 Added 28.25%	13,801 $811,000
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $117,160 - $170,260	-2,525 Reduced 19.0%	10,761 $600,000
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $66,236 - $86,399	1,346 Added 11.27%	13,286 $853,000
Q2 2019 Jul 24, 2019	SELL	$44.62 - $49.34 $532,762 - $589,119	-11,940 Reduced 50.0%	11,940 $541,000
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $538,732 - $642,372	11,940 Added 100.0%	23,880 $1.14 Million
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $5,948 - $7,714	-122 Reduced 1.01%	11,940 $621,000
Q2 2018 Aug 07, 2018	SELL	$50.53 - $62.98 $142,747 - $177,918	-2,825 Reduced 18.98%	12,062 $668,000
Q1 2018 May 03, 2018	SELL	$59.92 - $68.98 $51,531 - $59,322	-860 Reduced 5.46%	14,887 $942,000
Q4 2017 Feb 07, 2018	BUY	$59.94 - $65.35 $7,312 - $7,972	122 Added 0.78%	15,747 $965,000
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $862,968 - $995,937	15,625	15,625 $996,000

Others Institutions Holding BMY

# of Institutions

2,764

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $128B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Yale Capital Corp., based on Form 13F filings with the SEC.

News

Stay updated on Texas Yale Capital Corp. with notifications on news.

Account

Texas Yale Capital Corp. Bristol Myers Squibb CO Transaction History